News About: Pharm. Industry


KHIDI to support total 562 cases of functional health food researches.

Number of the current functional food research projects supported by the government is the total 562 cases including 144 by the Ministry of Agriculture, 130 by the Ministry of Science and Technology, 91 by the MOHW an...

Separated registration system premature to implement soon.

The domestic pharmaceutical manufacturers group expressed an opposing attitude against the impending government movement of revising the current Pharmaceutical Affairs Act, key subjects of which are now under the proc...

Backdoor payment of margins on the rise.

So called a backdoor payment of the irregular distribution margins showed ever rising tendency. Through a reliable source on Jan. 17, it is said that in Gyeonggi provincial areas where the competition severely prevail...

Yuhan/Viromed jointly to develop therapy for chronic granulomas.

Yuhan signed an agreement with Viromed Inc., a biotech company of Korea, at the head office on Jan. 18 for a joint research and development of a gene therapeutic compound VM106 for the treatment of chronic granulomas,...

Inaugural ceremony of new president Guenter Reinke of Boehringer Ing. Korea.

Boehringer Ingelheim Korea took an inaugural ceremony for the new president, Guenter Reinke and a new year greeting at Seoul Grand Hilton hotel on Jan. 13 in attendance of Chairman Han Tae-won and 270 company staffs. ...

KFDA instructed not to use amantadine anti-viral drugs.

The KFDA recommended, in the circulation letters for the physicians and pharmacists, not to use the anti-viral drug containing amantadine and remantadine including Hanwha's PK-Merz tablet for the treatment of A type f...

Bio Korea patented test composite and its methods for TB bacteria.

Bio Korea announced on Dec. 20, last year that the company completed the PCT international patent for the primer composite and process of the TB bacteria test The new test targeted on the unique part of TB bacteria...

Separated pharmaceutical registration system should be limitedly applied.

The pharmaceutical industry took a cautious position on the amendment of the pharmaceutical affairs act covering the separated registration system applicable to the pharmaceutical business and products of the new chem...

Daewoong to license in Phenserine, an Alzheimer drug.

Daewoong has agreed with Axonyx for the exclusive distribution of Phenserine (phenserine tartrate), an Alzheimer drug, in Korea. The Phenserine's mode of pharmacological action is to block a production of beta amyl...

Public hearing on separated product and manufacturing business licence

A public hearing on the subject of "Revised pharmaceutical affairs act covering the separated product and business licence" was scheduled to hold at the auditorium of the National Assembly Representative's House at 2:...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.